Bigger data = better data: detect 7,000 proteins at once with high throughput to optimize biomarker discovery
Abstract
The ideal biomarkers are waiting to be revealed within the human proteome. Big data from many thousands of protein analytes leads to superior biomarker models across therapeutic areas. In this webinar, you will discover how machine learning can be harnessed to select the right targets and build the right models for your research. You will also learn how to develop models, identify and mediate clinical risk, and elevate your research with greater precision than ever.
Joe Gogain, PhD
Clinical R&D at SomaLogic
Joe Gogain is a Director of Clinical Research and Development at SomaLogic, Inc., where he works closely with collaborating partners developing diagnostic and prognostic proteomic applications. Joe is a biological scientist with molecular diagnostic and immunoassay development expertise. Joe has a proven track record of IVD product development under design control and experience in de novo 510(k) regulatory submission processes and requirements. Additionally, Joe has served as a director of national clinical trials for point-of-care diagnostic devices and has experience managing a variety of technicians, scientists and clinical operations personnel.
Bigger Data = Better Data: Detect 7,000 proteins at once with high throughput to optimize biomarker discovery
A webinar presented by Joe Gogain, PhD
More webinars
WebinarDetecting growing tumors through changes in the plasma proteome
In this GEN webinar, Nebojsa Janjic, PhD, will discuss the need for a reliable blood-based screening method capable of detecting cancers earlier. During the webinar, he will highlight results from a study involving researchers from SomaLogic and the University of Colorado School of Medicine that used a test capable of measuring 5000 proteins simultaneously.
WebinarIdentifying Biomarkers for IBD Diagnosis and Management
In this webinar, you’ll hear how proteomics technology can enhance the identification of biomarkers for the accurate diagnosis of Crohn’s disease and ulcerative colitis, as well as the identification of biomarkers that predict response to TNF inhibitors and other biologics in patients with IBD.
WebinarBoutique Webinar : Predicting Pregnancy Complications with High-Plex Proteomics
The interdisciplinary team, comprising 10-15 scientists and clinician-scientists, is dedicated to advancing diagnostics and therapeutics aimed at enhancing maternal and fetal care. Their primary focus lies in the development of interventions for conditions such as ectopic pregnancy and preeclampsia, alongside the creation of diagnostics to prevent stillbirth.